PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 12, 2026ESMO rare cancers.0 citationsOpen Access

177P Outcomes and determinants of recurrence in patients with non-metastatic angiosarcoma managed in a tertiary center: A cohort study

View Full Paper
EBE.A. BaccaliniCVCarmine ValenzaSCSara Coppola

Key Result

Patients with non-metastatic angiosarcoma had a significant recurrence rate, highlighting the need for attentive management post-treatment.

Key Points

  • The aim is to identify outcomes and factors affecting recurrence in patients with non-metastatic angiosarcoma.
  • Conducted a cohort study in a tertiary center
  • Analyzed clinical data of patients with non-metastatic angiosarcoma
  • Examined outcomes related to recurrence and management strategies
  • Identified significant determinants of recurrence in non-metastatic cases
  • Management approaches varied and impacted patient outcomes
  • Real-world data highlighted the ultra-rare nature of cardiac sarcoma

Structured PICO

P
Population
Patients with non-metastatic angiosarcoma (primary cardiac sarcoma) managed in a tertiary center
O
Outcome
Outcomes and determinants of recurrence

Abstract

Background: Primary cardiac sarcoma is an ultra-rare tumor; this series presents real-world data on its clinical characteristics and management.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Baccalini et al. (2026) studied this question. Patients with non-metastatic angiosarcoma had a significant recurrence rate, highlighting the need for attentive management post-treatment.

synapsesocial.com/papers/69b2584996eeacc4fcec7d18https://doi.org/10.1016/j.esmorc.2026.100383
Ask AI
Helpful
Bookmark
Share
View Full Paper